Poly(ADP-ribose) polymerase 1 inhibition improves coronary arteriole function in type 2 diabetes mellitus.
about
Enhanced NF-κB activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes.Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity.Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 CascadeAssociation of three SNPs in the PARP-1 gene with Hashimoto's thyroiditis.Nuclear factor kappa B inhibition improves conductance artery function in type 2 diabetic miceRed blood cell count as an indicator of microvascular complications in Chinese patients with type 2 diabetes mellitus.Therapeutic applications of PARP inhibitors: anticancer therapy and beyondCoronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice.Enhanced p22phox expression impairs vascular function through p38 and ERK1/2 MAP kinase-dependent mechanisms in type 2 diabetic mice.Poly(ADP-ribose) polymerase 1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications.Discussion of PARP inhibitors in cancer therapy.1,25(OH)2 D3 improves cardiac dysfunction, hypertrophy, and fibrosis through PARP1/SIRT1/mTOR-related mechanisms in type 1 diabetes.Current perspectives in coronary microvascular dysfunction.Inhibition of endoplasmic reticulum stress improves coronary artery function in type 2 diabetic mice.Differential role for stromal interacting molecule 1 in the regulation of vascular function.PARP-1 Variant Rs1136410 Confers Protection against Coronary Artery Disease in a Chinese Han Population: A Two-Stage Case-Control Study Involving 5643 Subjects.Arsenic, Cadmium, and Lead Like Troglitazone Trigger PPARγ-Dependent Poly (ADP-Ribose) Polymerase Expression and Subsequent Apoptosis in Rat Brain Astrocytes.Relationship between apoptosis and survival molecules in human cumulus cells as markers of oocyte competence.Poly(ADP-ribose) polymerase 1 deficiency increases nitric oxide production and attenuates aortic atherogenesis through downregulation of arginase II.
P2860
Q30540016-0CE8C20F-F8EE-49C6-80E6-D424AB658DF7Q35707164-F400EB76-251B-4019-99C7-04CF166DE7C6Q35961020-D45ABC8F-EDB1-4C77-A7E4-F2B14A7212F9Q36671116-8C3F2408-52BB-46D6-804C-4781AAEE6252Q36791018-C3B7558A-877F-4C53-B9CF-A46548A44529Q36852051-19BA51B7-0EEB-4AFF-A1B0-9CB66C355461Q36853236-EF938F35-EA00-468C-9D4C-5293D1711CB0Q37341923-48957748-3545-47D4-83FA-BE5F33DE945AQ37656092-931E9F95-E052-4F35-B496-E3BCBB90EC33Q38134049-AF344F82-3FC0-4BB6-9A09-B2A362D4394BQ38163013-06BF7B12-0E8C-4A7A-A552-175298A6F5C1Q38750106-CC55F7E1-1D8E-4C80-94F0-D73A35127910Q39038913-46B9EE12-7753-4515-A21F-CA115ED36A1FQ39909761-517DE3BF-7E10-475A-A06A-658F6D90AD95Q40595029-FF847CB9-F2DF-43E1-BA55-7B958E956EB2Q46114975-AA11312F-3C39-4989-A661-E48CC4880A85Q48137852-FB015474-2686-4069-B47B-AE85F4EB7051Q48515457-439EB83C-A95A-4669-BA0C-3D8DD4ABCCFDQ51376719-F9469E67-A41C-4065-BEA5-09FA08251F2D
P2860
Poly(ADP-ribose) polymerase 1 inhibition improves coronary arteriole function in type 2 diabetes mellitus.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Poly(ADP-ribose) polymerase 1 ...... n in type 2 diabetes mellitus.
@ast
Poly(ADP-ribose) polymerase 1 ...... n in type 2 diabetes mellitus.
@en
type
label
Poly(ADP-ribose) polymerase 1 ...... n in type 2 diabetes mellitus.
@ast
Poly(ADP-ribose) polymerase 1 ...... n in type 2 diabetes mellitus.
@en
prefLabel
Poly(ADP-ribose) polymerase 1 ...... n in type 2 diabetes mellitus.
@ast
Poly(ADP-ribose) polymerase 1 ...... n in type 2 diabetes mellitus.
@en
P2093
P2860
P1433
P1476
Poly(ADP-ribose) polymerase 1 ...... on in type 2 diabetes mellitus
@en
P2093
Khalid Matrougui
Megan Partyka
Modar Kassan
Mohamed Trebak
P2860
P304
P356
10.1161/HYPERTENSIONAHA.111.190140
P407
P577
2012-03-26T00:00:00Z